In 2025, the FDA granted approval for Lumateperone as an adjunctive therapy for major depressive disorder (MDD) in adults.
27/12/2025
Suzetrigine – Hoạt chất giảm đau không opioid mới: Tiềm năng thay thế opioid trong đau cấp
23/12/2025
Predicting Pregnancy Complications: Is BMI Enough, or Are Blood Metabolic Profiles Better?
22/12/2025
Mối liên hệ giữa trầm cảm và nguy cơ suy giảm nhận thức: 6 dấu hiệu không thể phớt lờ
17/12/2025
Chạy Marathon Cường Độ Cao Có Thể Liên Quan Đến Nguy Cơ Tổn Thương Tiền Ung Thư Đại Tràng?
Cập nhật tin tức quốc tế
Recent research suggests that blood-based metabolomic profiling—particularly in late pregnancy—may identify hidden metabolic risks more accurately than body mass index (BMI) alone.
A watch-and-wait approach showed excellent disease control in selected rectal cancer patients with complete response after neoadjuvant therapy
A new FDA memo has sparked controversy by claiming Covid-19 vaccines may have caused at least 10 child deaths
Semaglutide showed no cognitive benefit in early Alzheimer’s, but emerging biomarker signals hint at potential future research paths.
New studies indicate that lower LDL-C levels are associated with a higher risk of developing type 2 diabetes, regardless of statin use.
Recent studies indicate that hydralazine, a common medication for hypertension, has the potential to halt the growth of aggressive brain cancer.
A recent randomized study shows that drinking one cup of caffeinated coffee a day may reduce atrial fibrillation (AFib) recurrence by up to 39%.
Impact of cumulative blood pressure load during early pregnancy on the risk of low birth weight: the BOSHI study